Zheng Chang is an assistant professor at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, where he has been a faculty member since 2017. He completed his PhD in psychiatric epidemiology at Karolinska Institutet with his thesis on the causes and consequences of ADHD. After graduation, he did postdoc at University of Oxford and University of Chicago.
Zheng’s research has focused on understanding the risks and benefits of prescribed psychotropic medications (e.g., ADHD medications, antidepressants) using large population-based data (e.g., national health registers, medical claims data). He has strong skills in advanced pharmacoepidemiology designs and statistical analyses. He has collaborated actively with researchers around the world, and has been PI and Co-I for several pharmacoepidemiology studies, funded from the Nordic countries and the US.
All Sessions by Zheng Chang
Friday 4 October
Symposium: Breakthroughs and controversies in ADHD
10:30 - 12:00
Chair: Larry Klassen, Eden Mental Health Centre, Canada and Eva-Maria Tsapakis, 'Aghios Charalambos' Mental Health Clinic, Greece
10:30-10:55: Treatment of ADHD: a pharmacoepidemiological approach - Zheng Chang, Karolinska Institutet, Sweden
11:00-11:25: ADHD Treatment in adults - Larry Klassen, Eden Mental Health Centre, Canada
11:30-11:55: Meta-analysis in ADHD response - Andrea Cipriani, Oxford University, United Kingdom
CINP2019 is a 2.5-day international meeting that will feature plenaries, meet the expert sessions, satellite symposia as well as interactive educational workshops.
Keep up to date with Conference News & Alerts. Sign Up
International Conference Services GmbH
Gonzagagasse 17, 1010 Vienna, Austria